AB0078 NESFATIN-1 EXPRESSION ASSOCIATED WITH A MARKER FOR BONE MATRIX FORMATION P1NP IN RHEUMATOID ARTHRITIS

Author:

Seewordova L.,Polyakova J.,Papichev E.,Akhverdyan Y.,Zavodovsky В.

Abstract

BackgroundCurrently, the role of tissue cytokines in the pathogenesis of various diseases is being actively studied [1,2]. Nesfatin-1 (NF-1) is an endogenous peptide with pleiotropic activity. Recently, there have been works on the involvement of NF-1 in osteogenesis. In the experiment, intravenous administration of NF-1 to ovariectomized rats (OVX) leads to an increase in bone mineral density (BMD). There are works showing inhibition of osteoclastogenesis in mice [3,4]. We assume that the level of NF-1 affects the processes of bone matrix formation.The aim of the study was to determine the relationship between the level of NF-1, bone mineral density, composite body composition and markers of bone metabolism in patients with rheumatoid arthritis (RA).ObjectivesThe study randomized 110 patients with RA according to the ACR/EULAR criteria, 2010 and 30 people in the control group.MethodsAll of them underwent osteodensitometry LUNAR DPX-Pro with the determination of composite body composition (BCT) and bone mineral density (BMD). NF-1 levels and bone turnover markers were determined using a commercial ELISA test.ResultsThe average concentration of NF-1 in patients with RA was 50.49±34.05 ng/ml, which is significantly higher than in healthy individuals. The average level of NF-1 in the blood serum of healthy individuals was 31.61±3.17 ng/ml (M±σ). The level of reference indicators of NF-1 in healthy individuals, defined as М±2σ, ranged from 25.27 to 37.95 ng/ml.According to the level of NF-1, all patients with RA were divided into 2 subgroups. The 1st group included patients (n=44) with normal serum NF-1 concentration (less than 37.95 ng/ml), the 2nd group (n=66) included patients with elevated NF-1 levels (more than ng/ml).During the analysis of the results of the study, we revealed a statistically significant correlation between NF-1 and the N-terminal propeptide of type I procollagen (P1NP)) (r = 0.218, p = 0.022). The level of CRP and the erythrocyte sedimentation rate positively correlated with the indicators of NF-1.However, we found no relationship between NF-1 levels and BMD; composite body composition; as well as the level of C-terminal type I collagen telopeptide (β-CTx).ConclusionThus, the relationship between nesfatin-1 and a marker of bone matrix formation (P1NP) was revealed. This may indicate a possible effect of nesfatin-1 on the differentiation and function of osteoblasts.References[1]Kvlividze T. Z., Zavodovsky B. V., Akhverdyan Y. R., Sivordova (Seewordova) L. E., Polyakova Yu.V., Lavrov D.P., A.T. Yakovlev. Elevated Nesfatin-1 levels in patients with Rheumatoid arthritis. Annals of the Rheumatic Diseases. 2018; DOI: 10.1136/annrheumdis-2018-eular.4459 (In Russ.).[2]Polyakova YV, Zavodovsky BV, Sivordova LE, Akhverdyan YR, Zborovskaya IA. Visfatin and Rheumatoid Arthritis: Pathogenetic Implications and Clinical Utility. Curr Rheumatol Rev. 2020;16(3):224-239. doi: 10.2174/1573397115666190409112621. PMID: 30963978.[3]Chen D., Cao S., Chang B., et al. Increasing hypothalamic nucleobindin 2 levels and decreasing hypothalamic inflammation in obese male mice via diet and exercise alleviate obesity-associated hypogonadism. neuropeptides. 2019 Apr;74:34-43. doi: 10.1016/j.npep.2018.10.005. Epub 2018 Nov 1.[4]Li R., Wu Q., Zhao Y., et. Al. The novel pro-osteogenic activity of NUCB2(1-83). PLoS One. 2013. (4):e61619.Disclosure of InterestsNone declared

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3